Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor β II receptor

Journal of Experimental Medicine

Volumn 191, Issue 7, 2000, Pages 1187-1196

  Lucas, Philip J ^a   Kim, Seong Jin ^b   Melby, Spencer J ^a   Gress, Ronald E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Lymphoproliferative disorder; T cell transformation; T lymphocyte subsets; TCR repertoire; Thymocyte development

Indexed keywords

HERMES ANTIGEN; MUTANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IMMUNOPATHOGENESIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE; TISSUE SPECIFICITY; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; BINDING SITES; CD8-POSITIVE T-LYMPHOCYTES; CELL CYCLE; CELL LINE; HOMEOSTASIS; HUMANS; IMMUNOPHENOTYPING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; THYMUS GLAND; TIME FACTORS;

EID: 0034600070     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.7.1187     Document Type: Article

References (61)

1. Kingsley, D.M. 1994. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8:133-146.
2. Letterio, J.J., and A.B. Roberts. 1996. Transforming growth factor-beta1-deficient mice: identification of isoform-specific activities in vivo. J. Leukoc. Biol. 59:769-774.
3. Ruscetti, F., L. Varesio, A. Ochoa, and J. Ortaldo. 1993. Pleiotropic effects of transforming growth factor-beta on cells of the immune system. Ann. NY Acad. Sci. 685:488-500.
4. Wahl, S.M., J.B. Allen, B.S. Weeks, H.L. Wong, and P.E. Klotman. 1993. Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. Proc. Natl. Acad. Sci. USA. 90:4577-4581.
5. Gamble, J.R., Y. Khew-Goodall, and M.A. Vadas. 1993. Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells. J. Immunol. 150:4494-4503.
6. Hines, K.L., A.B. Kulkarni, J.B. McCarthy, H. Tian, J.M. Ward, M. Christ, N.L. McCartney-Francis, L.T. Furcht, S. Karlsson, and S.M. Wahl. 1994. Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice. Proc. Natl. Acad. Sci. USA. 91:5187-5191.
7. Cutolo, M., A. Sulli, A. Barone, B. Seriolo, and S. Accardo. 1993. Macrophages, synovial tissue and rheumatoid arthritis. Clin. Exp. Rheumatol. 11:331-339.
8. Fontana, A., D.B. Constam, K. Frei, U. Malipiero, and H. W. Pfister. 1992. Modulation of the immune response by transforming growth factor beta. Int. Arch. Allergy Immunol. 99:1-7.
9. Vodovotz, Y., C. Bogdan, J. Paik, Q.W. Xie, and C. Nathan. 1993. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med. 178:605-613.
10. Zhao, Y., and S. L. Young. 1996. Requirement of transforming growth factor-beta (TGF-beta) type II receptor for TGF-beta-induced proliferation and growth inhibition. J. Biol. Chem. 271:2369-2372.
11. Lowrance, J.H., F.X. O'Sullivan, T.E. Caver, W. Waegell, and H.D. Gresham. 1994. Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice. J. Exp. Med. 180:1693-1703.
12. Young, M.R., M.A. Wright, J.P. Matthews, I. Malik, and M. Prechel. 1996. Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-β and nitric oxide. J. Immunol. 156:1916-1922.
13. Shull, M.M., I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, K. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 359:693-699.
14. Kulkarni, A.B., C.G. Huh, D. Becker, A. Geiser, M. Lyght, K.C. Flanders, A.B. Roberts, M.B. Sporn, J.M. Ward, and S. Karlsson. 1993. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA. 90:770-774.
15. Diebold, R.J., M.J. Eis, M. Yin, I. Ormsby, G.P. Boivin, B.J. Harrow, J.E. Saffitz, and T. Doetschman. 1995. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc. Natl. Acad. Sci. USA. 92:12215-12219.
16. Koevary, S.B. 1994. Prevention of diabetes in BB/W or rats by injection of peritoneal exudate cells cultured in the presence of transforming growth factor beta (TGF-beta) and islet cells. Diabetes Res. 27:1-14.
17. Dang, H., A.G. Geiser, J.J. Letterio, T. Nakabayashi, L. Kong, G. Fernandes, and N. Talal. 1995. SLE-like autoantibodies and Sjogren's syndrome-like lymphoproliferation in TGF-beta knockout mice. J. Immunol. 155:3205-3212.
18. Letterio, J.J., A.G. Geiser, A.B. Kulkarni, H. Dang, L. Kong, T. Nakabayashi, C.L. Mackall, R.E. Gress, and A.B. Roberts. 1996. Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression. J. Clin. Invest. 98:2109-2119.
19. Winkler, S., S. Paiha, H. Winkler, W. Graninger, M. Marberger, and G.E. Steiner. 1996. Microfilarial clearance in loiasis involves elevation of Th1 and Th2 products and emergence of a specific pattern of T-cell populations. Parasite Immunol. 18:479-482.
20. Morris, M.M., H. Dyson, D. Baker, L.S. Harbige, J.K. Fazakerley, and S. Amor. 1997. Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection. J. Neuroimmunol. 74:185-197.
21. Kanagawa, O., B.A. Vaupel, S. Gayama, G. Koehler, and M. Kopf. 1993. Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS) [see comments]. Science. 262:240-242.
22. Guler, M.L., J.D. Gorham, C.S. Hsieh, A.J. Mackey, R.G. Steen, W.F. Dietrich, and K.M. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 respomiveness in TH1 cell development [see comments]. Science. 271:984-987.
23. Nakajima, H., E.W. Shores, M. Noguchi, and W.J. Leonard. 1997. The common cytokine receptor gamma chain plays an essential role in regulating lymphoid homeostasis. J. Exp. Med. 185:189-195.
24. Sohn, S.J., K.A. Forbush, N. Nguyen, B. Witthuhn, T. Nosaka, J.N. Ihle, and R.M. Perlmutter. 1998. Requirement for Jak3 in mature T cells: its role in regulation of T cell homeostasis. J. Immunol. 160:2130-2138.
25. Lodolce, J.P., D.L. Boone, S. Chai, R.E. Swain, T. Dassopoulos, S. Trettin, and A. Ma. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity. 9:669-676.
26. + T cells from IRF-1-deficient mice exhibit altered patterns of cytokine expression and cell subset homeostasis. J. Immunol. 159:4180-4186.
27. Matsuyama, T., T. Kimura, M. Kitagawa, K. Pfeffer, T. Kawakami, N. Watanabe, T.M. Kundig, R. Amakawa, K. Kishihara, A. Wakeham, et al. 1993. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell. 75:83-97.
28. + T cells. Eur. Immunol. 25:3053-3059.
29. Senju, S., I. Negishi, N. Motoyama, F. Wang, K.I. Nakayama, K. Nakayama, P.J. Lucas, S. Hatakeyama, Q. Zhang, S. Yonehara, et al. 1996. Functional significance of the Fas molecule in naive lymphocytes. Int. Immunol. 8:423-431.
30. + T cells. Immunity. 7:885-895.
31. Ebner, R., R.H. Chen, L. Shum, S. Lawler, T.F. Zioncheck, A. Lee, A.R. Lopez, and R. Derynck. 1993. Cloning of a type 1 TGF-beta receptor and its effect on TGF-beta binding to the type II receptor. Science. 260:1344-1348.
32. Chen, R.H., R. Ebner, and R. Derynck. 1993. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities. Science. 260:1335-1338.
33. Zhumabekov, T., P. Corbella, M. Tolaini, and D. Kioussis. 1995. Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice. J. Immunol. Methods. 185:133-140.
34. Waegell, W.O., H.R. Higley, P.W. Kincade, and J.R. Dasch. 1994. Growth acceleration and stem cell expansion in Dexter-type cultures by neutralization of TGF-beta. Exp. Hematol. 22:1051-1057.
35. Lucas, P.J., I. Negishi, K. Nakayama, L.E. Fields, and D.Y. Loh. 1995. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154:5757-5768.
36. Park, K., S.-J. Kim, Y.-J. Bang, J.-G. Park, N.K. Kim, A.A. Roberts, and M.B. Sporn. 1994. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. USA. 91: 8772-8776.
37. Takahama, Y., J.J. Letterio, H. Suzuki, A.G. Farr, and A. Singer. 1994. Early progression of thymocytes along the CD4/CD8 developmental pathway is regulated by a subset of thymic epithelial cells expressing transforming growth factor beta. J. Exp. Med. 179:1495-1506.
38. Rocha, B., N. Dautigny, and P. Pereira. 1989. Peripheral T lymphocytes: expansion potential and homeostatic regulation of pool sizes and CD4/CD8 ratios in vivo. Eur. J. Immunol. 19:905-911.
39. Tanchot, C., M.M. Rosado, F. Agenes, A.A. Freitas, and U. Rocha. 1997. Lymphocyte homeostasis. Semin. Immunol. 9:331-337.
40. + T cell pools. Eur J. Immunol. 25:2127-2136.
41. Wang, X.J., D.A. Greenhalgh, J.R. Bickenbach, A. Jiang, D.S. Bundman, T. Krieg, R. Derynck, and D.R. Roop. 1997. Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition. Proc. Natl. Acad. Sci. USA. 94:2386-2391.
42. Aspinall, R. 1997. Age-associated thymic atrophy in the mouse is due to a deficiency affecting rearrangement of the TCR during intrathymic T cell development. J. Immunol. 158:3037-3045.
43. Greaves, D.R., F.D. Wilson, G. Lang, and D. Kioussis. 1989. Human CD2 3'-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice. Cell. 56:979-986.
44. Maraskovsky, E., M. Teepe, P.J. Morrissey, S. Braddy, R.E. Miller, D.H. Lynch, and J.J. Peschon. 1996. Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells. J. Immunol. 157:5315-5323.
45. + T cells in vivo by IL-15. Immunity. 8:591-599.
46. Willerford, D.M., J. Chen, J.A. Ferry, L. Davidson, A. Ma, and F.W. Alt. 1995. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity. 3:521-530.
47. Suzuki, H., T.M. Kundig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J.J. Simard, P.S. Ohashi, H. Griesser, et al. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science. 268:1472-1476.
48. Waterhouse, P., L.E. Marengere, H.W. Mittrucker, and T.W. Mak. 1996. CTLA-4, a negative regulator of T-lymphocyte activation. Immunol. Rev. 153:183-207.
49. Waterhouse, P., M.F. Machmann, J.M. Penninger, P.S. Ohashi, and T.W. Mak. 1997. Normal thymic selection, normal viability and decreased lymphoproliferation in T cell receptor-transgenic CTLA-4-deficient mice. Eur. J. Immunol. 27:1887-1892.
50. Yang, H.Y., P.L. Dundon, S.R. Nahill, and R.M. Welsh. 1989. Virus-induced polyclonal cytotoxic T lymphocyte stimulation. J. Immunol. 142:1710-1718.
51. Buchmeier, M.J., R.M. Welsh, F.J. Dutko, and M.B. Oldstone. 1980. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30: 275-331.
52. Rubin, R.H., W.P. Carney, R.T. Schooley, R.B. Colvin, R.C. Burton, R.A. Hoffman, W.P. Hansen, A.B. Cosimi, P.S. Russell, and M.S. Hirsch. 1981. The effect of infection on T lymphocyte subpopulations: a preliminary report. Int. J. Immunopharmacol. 3:307-312.
53. Oldstone, M.B., M.J. Buchmeier, M.V. Doyle, and A. Tishon. 1980. Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection. J. Immunol. 124:831-838.
54. + T cells during an acute virus infection. Immunity. 8:167-175.
55. + T cells in Kawasaki disease. J. Immunol. 159:481-186.
56. + T cell memory in the absence of B cells and Ig. J. Immunol. 157:2947-2952.
57. + memory T cells in virus-infected hosts. J. Exp. Med. 183:1367-1375.
58. Tough, D.F., S. Sun, and J. Sprent. 1997. T cell stimulation in vivo by lipopolysaccharide (LPS). J. Exp. Med. 185:2089-2094.
59. Sprent, J., and D.F. Tough. 1994. Lymphocyte life-span and memory. Science. 265:1395-1400.
60. Tough, D.F., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type I interferon in vivo [see comments]. Science. 272:1947-1950.
61. Ulloa, L., J. Doody, and J. Massague. 1999. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature. 397:710-713.